Value of CT quantification in progressive fibrosing interstitial lung disease: a deep learning approach

被引:8
作者
Koh, Seok Young [1 ]
Lee, Jong Hyuk [1 ]
Park, Hyungin [1 ]
Goo, Jin Mo [1 ,2 ,3 ,4 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiol, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Radiol, 101 Daehak Ro, Seoul 03080, South Korea
[3] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, 101 Daehak Ro, Seoul 03080, South Korea
[4] Seoul Natl Univ, Canc Res Inst, 101 Daehak Ro, Seoul 03080, South Korea
关键词
Lung diseases (Interstitial); Quantitative evaluation; Deep learning; Prognosis; Multidetector computed tomography; IDIOPATHIC PULMONARY-FIBROSIS; FORCED VITAL CAPACITY; RESOLUTION COMPUTED-TOMOGRAPHY; DIABETIC-RETINOPATHY; CLASSIFICATION; PIRFENIDONE; VALIDATION; PNEUMONIA; DIAGNOSIS; PATTERNS;
D O I
10.1007/s00330-023-10483-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives To evaluate the relationship of changes in the deep learning-based CT quantification of interstitial lung disease (ILD) with changes in forced vital capacity (FVC) and visual assessments of ILD progression, and to investigate their prognostic implications.Methods This study included ILD patients with CT scans at intervals of over 2 years between January 2015 and June 2021. Deep learning-based texture analysis software was used to segment ILD findings on CT images (fibrosis: reticular opacity + honeycombing cysts; total ILD extent: ground-glass opacity + fibrosis). Patients were grouped according to the absolute decline of predicted FVC (< 5%, 5-10%, and >= 10%) and ILD progression assessed by thoracic radiologists, and their quantification results were compared among these groups. The associations between quantification results and survival were evaluated using multivariable Cox regression analysis.Results In total, 468 patients (239 men; 64 +/- 9.5 years) were included. Fibrosis and total ILD extents more increased in patients with larger FVC decline (p < .001 in both). Patients with ILD progression had higher fibrosis and total ILD extent increases than those without ILD progression (p < .001 in both). Increases in fibrosis and total ILD extent were significant prognostic factors when adjusted for absolute FVC declines of >= 5% (hazard ratio [HR] 1.844, p = .01 for fibrosis; HR 2.484, p < .001 for total ILD extent) and >= 10% (HR 2.918, p < .001 for fibrosis; HR 3.125, p < .001 for total ILD extent).Conclusion Changes in ILD CT quantification correlated with changes in FVC and visual assessment of ILD progression, and they were independent prognostic factors in ILD patients.
引用
收藏
页码:4195 / 4205
页数:11
相关论文
共 39 条
[1]   Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial [J].
Behr, Juergen ;
Neuser, Petra ;
Prasse, Antje ;
Kreuter, Michael ;
Rabe, Klaus ;
Schade-Brittinger, Carmen ;
Wagner, Jasmin ;
Guenther, Andreas .
BMC PULMONARY MEDICINE, 2017, 17
[2]   Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer [J].
Bejnordi, Babak Ehteshami ;
Veta, Mitko ;
van Diest, Paul Johannes ;
van Ginneken, Bram ;
Karssemeijer, Nico ;
Litjens, Geert ;
van der Laak, Jeroen A. W. M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (22) :2199-2210
[3]   Training and Validating a Deep Convolutional Neural Network for Computer-Aided Detection and Classification of Abnormalities on Frontal Chest Radiographs [J].
Cicero, Mark ;
Bilbily, Alexander ;
Dowdell, Tim ;
Gray, Bruce ;
Perampaladas, Kuhan ;
Barfett, Joseph .
INVESTIGATIVE RADIOLOGY, 2017, 52 (05) :281-287
[4]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[5]   Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference [J].
du Bois, Roland M. ;
Weycker, Derek ;
Albera, Carlo ;
Bradford, Williamson Z. ;
Costabel, Ulrich ;
Kartashov, Alex ;
King, Talmadge E., Jr. ;
Lancaster, Lisa ;
Noble, Paul W. ;
Sahn, Steven A. ;
Thomeer, Michiel ;
Valeyre, Dominique ;
Wells, Athol U. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (12) :1382-1389
[6]   Dermatologist-level classification of skin cancer with deep neural networks [J].
Esteva, Andre ;
Kuprel, Brett ;
Novoa, Roberto A. ;
Ko, Justin ;
Swetter, Susan M. ;
Blau, Helen M. ;
Thrun, Sebastian .
NATURE, 2017, 542 (7639) :115-+
[7]   Nintedanib in Progressive Fibrosing Interstitial Lung Diseases [J].
Flaherty, K. R. ;
Wells, A. U. ;
Cottin, V ;
Devaraj, A. ;
Walsh, S. L. F. ;
Inoue, Y. ;
Richeldi, L. ;
Kolb, M. ;
Tetzlaff, K. ;
Stowasser, S. ;
Coeck, C. ;
Clerisme-Beaty, E. ;
Rosenstock, B. ;
Quaresma, M. ;
Haeufel, T. ;
Goeldner, R-G ;
Schlenker-Herceg, R. ;
Brown, K. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) :1718-1727
[8]   Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia [J].
Flaherty, KR ;
Mumford, JA ;
Murray, S ;
Kazerooni, EA ;
Gross, BH ;
Colby, TV ;
Travis, WD ;
Flint, A ;
Toews, GB ;
Lynch, JP ;
Martinez, FJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :543-548
[9]  
George PM, 2020, LANCET RESP MED, V8, P925, DOI 10.1016/S2213-2600(20)30355-6
[10]   Lung transplantation for idiopathic pulmonary fibrosis [J].
George, Peter M. ;
Patterson, Caroline M. ;
Reed, Anna K. ;
Thillai, Muhunthan .
LANCET RESPIRATORY MEDICINE, 2019, 7 (03) :271-282